| Joel Craig Hyman, MD | |
|
9303 Pinecroft Dr, Suite 150, The Woodlands, TX 77380-3180 | |
| (281) 363-5050 | |
| (281) 363-5020 |
| Full Name | Joel Craig Hyman |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 24 Years |
| Location | 9303 Pinecroft Dr, The Woodlands, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881774818 | NPI | - | NPPES |
| 1881774818 | Other | NPI | |
| P00474924 | Other | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | L8082 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Woodlands Dermatology Associates Pa | 0042202947 | 10 |
News Archive
The last two decades have seen an uptick in people choosing to monitor their health using wearable technologies such as Fitbits and Apple Watches.
Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA™ (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
Nearly one in 10 Americans report regularly using illegal drugs, including marijuana, cocaine, heroin, hallucinogens, inhalants or prescription drugs used recreationally, according to the National Survey on Drug Use and Health made public today. The survey, sponsored by the federal Substance Abuse and Mental Health Services Administration (SAMHSA), collects the data from interviews with 67,500 randomly selected people 12 years or older.
New research shows that the body's own microbes are effective in maintaining immune cells and killing certain oral infections.
ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today introduced an advanced respiratory clinical trial solution to centrally capture, measure and analyze Lung Clearance Index data, in near real-time, to assess lung performance with more precision than traditional spirometry measures.
› Verified 4 days ago
| Entity Name | The Woodlands Dermatology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619919958 PECOS PAC ID: 0042202947 Enrollment ID: O20040331001445 |
News Archive
The last two decades have seen an uptick in people choosing to monitor their health using wearable technologies such as Fitbits and Apple Watches.
Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA™ (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
Nearly one in 10 Americans report regularly using illegal drugs, including marijuana, cocaine, heroin, hallucinogens, inhalants or prescription drugs used recreationally, according to the National Survey on Drug Use and Health made public today. The survey, sponsored by the federal Substance Abuse and Mental Health Services Administration (SAMHSA), collects the data from interviews with 67,500 randomly selected people 12 years or older.
New research shows that the body's own microbes are effective in maintaining immune cells and killing certain oral infections.
ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today introduced an advanced respiratory clinical trial solution to centrally capture, measure and analyze Lung Clearance Index data, in near real-time, to assess lung performance with more precision than traditional spirometry measures.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joel Craig Hyman, MD 9303 Pinecroft Dr, Suite 150, The Woodlands, TX 77380-3180 Ph: (281) 363-5050 | Joel Craig Hyman, MD 9303 Pinecroft Dr, Suite 150, The Woodlands, TX 77380-3180 Ph: (281) 363-5050 |
News Archive
The last two decades have seen an uptick in people choosing to monitor their health using wearable technologies such as Fitbits and Apple Watches.
Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved KRYSTEXXA™ (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients refractory to conventional therapy. Chronic gout that is refractory to conventional therapy occurs in patients who have failed to normalize serum uric acid and whose signs and symptoms are inadequately controlled with xanthine oxidase inhibitors at the maximum medically appropriate dose or for whom these drugs are contraindicated.
Nearly one in 10 Americans report regularly using illegal drugs, including marijuana, cocaine, heroin, hallucinogens, inhalants or prescription drugs used recreationally, according to the National Survey on Drug Use and Health made public today. The survey, sponsored by the federal Substance Abuse and Mental Health Services Administration (SAMHSA), collects the data from interviews with 67,500 randomly selected people 12 years or older.
New research shows that the body's own microbes are effective in maintaining immune cells and killing certain oral infections.
ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today introduced an advanced respiratory clinical trial solution to centrally capture, measure and analyze Lung Clearance Index data, in near real-time, to assess lung performance with more precision than traditional spirometry measures.
› Verified 4 days ago
Dr. Andrew Decrescenzo, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9303 Pinecroft Dr Ste 310, The Woodlands, TX 77380 Phone: 281-363-5050 Fax: 281-363-5020 | |
Amy C Bumgardner, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9303 Pinecroft Dr, Suite 150, The Woodlands, TX 77380 Phone: 281-363-5050 | |
Stephen B Tucker, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1055 Evergreen Cir, The Woodlands, TX 77380 Phone: 281-367-9110 Fax: 832-813-0344 | |
Dr. Brent Andrew Shook, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8850 Six Pines Drive, Suite 290, The Woodlands, TX 77380 Phone: 281-364-8844 Fax: 281-364-8833 | |
Dr. Haneol Sam Jeong, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9303 Pinecraft Drive, Suite 150, The Woodlands, TX 77380 Phone: 281-363-5050 Fax: 281-363-5020 | |
Dr. Nhan Minh Nguyen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 17183 I 45 Suite 510, The Woodlands, TX 77385 Phone: 713-791-9966 | |
Mandy Sue Harting, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9303 Pinecroft Dr, Suite 150, The Woodlands, TX 77380 Phone: 281-363-5050 Fax: 281-296-2072 |